Oncology
Oncology
Advertisement
Oncology BrothersOncology Brothers | September 19, 2023
Dr. Jeff Sharman discusses the nuances of CLL management and how to treat the disease using an algorithm.
View More
Dr. Fahar MerchantOncology | September 18, 2023
Dr. Fahar Merchant, president and CEO of Medicenna, talks about a promising therapy for combating recurrent glioblastoma.
Patrick DalySOHO 2023 | September 14, 2023
Patients with ibrutinib dose reduction after an AE had longer treatment length and similar efficacy versus no dose reduction.
Patrick DalySOHO 2023 | September 14, 2023
A study on patterns in patients with CLL found the RFC regimen appeared to be most effective for OS and response rates.
Patrick DalySOHO 2023 | September 14, 2023
Patients with chronic lymphocytic leukemia experience more anxiety when receiving intravenous versus oral treatments.
Patrick DalySOHO 2023 | September 14, 2023
Patients with CLL who relapsed after HSCT and then received venetoclax therapy achieved outcomes consistent with trial data.
The Fellow on CallThe Fellow on Call | September 12, 2023
The group kicks off a new series on DLBCL, starting with the basics that come before disease management.
The Fellow on CallThe Fellow on Call | August 24, 2023
Kaele Leonard, a pulmonary/critical care fellow who was diagnosed with breast cancer at a young age, discusses her journey.
Healthcare UnfilteredHealthcare Unfiltered | August 22, 2023
Dr. Urvi Shah sheds light on how dietary changes can modify the microbiome and prevent cancer.
Rob DillardOncology | August 10, 2023
Researchers at the City of Hope developed a targeted chemotherapy that appears to destroy solid tumors.
The Fellow on CallThe Fellow on Call | July 31, 2023
The Fellow on Call: The Heme/Onc Podcast covers HER2-positive breast cancer in part 11 of its series on breast cancer types.
The Fellow on CallThe Fellow on Call | July 31, 2023
The Fellow on Call: The Heme/Onc Podcast switches from localized breast cancers to metastatic subtypes, starting with ER+.
Oncology BrothersOncology Brothers | July 31, 2023
Dr. S. Vincent Rajkumar and The Oncology Brothers develop an algorithm for patients with MGUS or smoldering multiple myeloma.
Rebecca AraujoOncology | July 31, 2023
MRI-guided adaptive radiation led to reduced genitourinary toxicity in prostate cancer radiotherapy.
Rebecca AraujoOncology | July 26, 2023
Prostate-specific membrane antigen PET imaging predicted prostate cancer recurrence risk post-surgery, even before operation.
Rob DillardOncology | July 25, 2023
A panel discussed the optimal treatment for patients with acute myeloid leukemia, as well as maintenance approaches.
Rob DillardOncology | July 25, 2023
Options for treating ALL have improved in recent years, but questions about treatment approaches remain.
Rob DillardOncology | July 25, 2023
There is no optimal initial therapy for patients with chronic lymphocytic leukemia, and multiple factors should be evaluated.
Healthcare UnfilteredHealthcare Unfiltered | July 25, 2023
Dr. Chadi Nabhan is joined by Dr. Ilana Yurkiewicz to discuss fragmentation within the health care system.
Oncology BrothersOncology Brothers | July 21, 2023
Dr. Jens Hillengass joins The Oncology Brothers to discuss an algorithm for treating multiple myeloma.
Advertisement
Advertisement
Advertisement
Latest News

September 22, 2023